"We are an outpatient clinic that treats adults with Sickle Cell Disease"

During the past decade, Methodist Adult Comprehensive Sickle Cell Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Adult Comprehensive Sickle Cell Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator, "Children's Hospital of Philadelphia" with 1 trials as a collaborator, "Le Bonheur Children's Hospital" with 1 trials as a collaborator and "Medical College of Wisconsin" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Adult Comprehensive Sickle Cell Center" are "Sickle Cell Disease" (2 trials). Many other conditions were trialed in "Methodist Adult Comprehensive Sickle Cell Center" in a lesser frequency.

The vast majority of trials in "Methodist Adult Comprehensive Sickle Cell Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Methodist Adult Comprehensive Sickle Cell Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Methodist Adult Comprehensive Sickle Cell Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Adult Comprehensive Sickle Cell Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".